
Product Specifications
Medikinet MR is indicated as part of a comprehensive treatment programme for attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years of age
and over and in adults with ADHD onset in childhood when remedial measures alone prove insufficient.
Company Information
Ask for more detail from the seller
Contact Supplier